251 related articles for article (PubMed ID: 18209965)
1. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile.
De La Cochetière MF; Durand T; Lalande V; Petit JC; Potel G; Beaugerie L
Microb Ecol; 2008 Oct; 56(3):395-402. PubMed ID: 18209965
[TBL] [Abstract][Full Text] [Related]
2. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge.
De La Cochetière MF; Durand T; Lepage P; Bourreille A; Galmiche JP; Doré J
J Clin Microbiol; 2005 Nov; 43(11):5588-92. PubMed ID: 16272491
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.
Rousseau C; Levenez F; Fouqueray C; Doré J; Collignon A; Lepage P
J Clin Microbiol; 2011 Mar; 49(3):858-65. PubMed ID: 21177896
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.
Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP
PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580
[TBL] [Abstract][Full Text] [Related]
5. Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile.
Peterfreund GL; Vandivier LE; Sinha R; Marozsan AJ; Olson WC; Zhu J; Bushman FD
PLoS One; 2012; 7(10):e46966. PubMed ID: 23071679
[TBL] [Abstract][Full Text] [Related]
6. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
[TBL] [Abstract][Full Text] [Related]
7. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
[TBL] [Abstract][Full Text] [Related]
8. Optimized PCR-Temporal Temperature Gel Electrophoresis compared to cultivation to assess diversity of gut microbiota in neonates.
Roudière L; Jacquot A; Marchandin H; Aujoulat F; Devine R; Zorgniotti I; Jean-Pierre H; Picaud JC; Jumas-Bilak E
J Microbiol Methods; 2009 Nov; 79(2):156-65. PubMed ID: 19686785
[TBL] [Abstract][Full Text] [Related]
9. PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.
Martirosian G; Kuipers S; Verbrugh H; van Belkum A; Meisel-Mikolajczyk F
J Clin Microbiol; 1995 Aug; 33(8):2016-21. PubMed ID: 7559940
[TBL] [Abstract][Full Text] [Related]
10. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.
Chang JY; Antonopoulos DA; Kalra A; Tonelli A; Khalife WT; Schmidt TM; Young VB
J Infect Dis; 2008 Feb; 197(3):435-8. PubMed ID: 18199029
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.
Stiefel U; Nerandzic MM; Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4535-42. PubMed ID: 24867962
[TBL] [Abstract][Full Text] [Related]
12. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria.
Zoetendal EG; Akkermans AD; De Vos WM
Appl Environ Microbiol; 1998 Oct; 64(10):3854-9. PubMed ID: 9758810
[TBL] [Abstract][Full Text] [Related]
13. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro.
Hopkins MJ; Macfarlane GT
Appl Environ Microbiol; 2003 Apr; 69(4):1920-7. PubMed ID: 12676665
[TBL] [Abstract][Full Text] [Related]
14. Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea.
Sepp E; Stšepetova J; Smidt I; Rätsep M; Kõljalg S; Lõivukene K; Mändar R; Jaanimäe L; Löhr IH; Natås OB; Naaber P
Anaerobe; 2011 Dec; 17(6):407-9. PubMed ID: 21549208
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea.
Cohen NA; Ben Ami R; Guzner-Gur H; Santo ME; Halpern Z; Maharshak N
Isr Med Assoc J; 2015 Aug; 17(8):510-4. PubMed ID: 26394495
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.
Mangin I; Lévêque C; Magne F; Suau A; Pochart P
PLoS One; 2012; 7(11):e50257. PubMed ID: 23209691
[TBL] [Abstract][Full Text] [Related]
17. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.
Ryan J; Murphy C; Twomey C; Paul Ross R; Rea MC; MacSharry J; Sheil B; Shanahan F
Ir J Med Sci; 2010 Jun; 179(2):245-50. PubMed ID: 19495833
[TBL] [Abstract][Full Text] [Related]
19. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.
Pituch H; van den Braak N; van Leeuwen W; van Belkum A; Martirosian G; Obuch-Woszczatyński P; Łuczak M; Meisel-Mikołajczyk F
Clin Microbiol Infect; 2001 Aug; 7(8):442-6. PubMed ID: 11591209
[TBL] [Abstract][Full Text] [Related]
20. Stool therapy may become a preferred treatment of recurrent Clostridium difficile?
Vyas D; L'esperance HE; Vyas A
World J Gastroenterol; 2013 Aug; 19(29):4635-7. PubMed ID: 23922461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]